Hite Christopher
- SEC CIK
- 0001814238
In the past year, 4 open-market sale filings worth $27.4M and no purchases.
Current role at each company
- RPRX Royalty Pharma plcEVP & Chairman, Partneringas of Sep 24, 2026
- KLRA Kailera Therapeutics, Inc.Directoras of Apr 20, 2026
- VERA Vera Therapeutics, Inc.Directoras of Mar 9, 2026
- XLRN Acceleron Pharma IncDirectoras of Nov 22, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $27.4M
- 4 filings
- Net
- −$27.4M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hite Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RPRX Royalty Pharma plc
EVP & Chairman, Partnering5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 (view filing)4:10 PM ET | Sep 22 | 2 days | Hite ChristopherEVP & Chairman, Partnering | SSaleClass A Ordinary Shares | −100.0K | $58.53 | −$5.85M | −27.0%270.4K after | 2 lots10b5-1 |
| Aug 19, 2026 (view filing)4:20 PM ET | Aug 18 | 1 day | Hite ChristopherEVP & Chairman, Partnering | SSaleClass A Ordinary Shares | −100.0K | $59.97 | −$6.00M | −21.3%370.4K after | 10b5-1 |
| Jul 2, 2026 (view filing)4:08 PM ET | Jun 30 | 2 days | Hite ChristopherEVP & Chairman, Partnering | SSaleClass A Ordinary Shares | −100.0K | $56.52 | −$5.65M | −17.9%459.4K after | 2 lots10b5-1 |
| Jul 2, 2026 (view filing)4:08 PM ET | Jun 30 | 2 days | Hite ChristopherEVP & Chairman, Partnering | SSaleClass A Ordinary Shares | −30.0K | $56.46 | −$1.69M | −42.9%40.0K after | 2 lots10b5-1 |
| Jun 25, 2026 (view filing) | Jun 23 | 2 days | Hite ChristopherEVP & Chairman, Partnering | SSaleClass A Ordinary Shares | −150.0K | $54.39 | −$8.16M | −21.1%559.4K after | 2 lots10b5-1 |